News
The prostate cancer section is a comprehensive resource for urology news and expert insights. Read more at Urology Times.
The Visby Medical test is the first at-home, prescription-free diagnostic for chlamydia, gonorrhea, and trichomoniasis. It provides results in approximately 30 minutes using a self-collected vaginal ...
In a retrospective study of almost 500 men, the use of hyaluronic acid filler for penile girth enhancement appeared safe with limited adverse events.
“At 60 months, nadofaragene allowed bladder preservation in nearly half of the patients in the CIS cohort and two-thirds of patients in the Ta/T1 cohort,” said Vikram Narayan, MD.
Low-intensity extracorporeal shock wave therapy is a safe treatment for men with erectile dysfunction and might work to improve, or even cure, ED in some patients. But there remain important ...
Anktiva is the first drug to rescue T and NK cells, crucial for cancer cell eradication and memory generation. The "triangle offense" involves NK cells, CD8 killer T cells, and memory T cells, forming ...
The American Urological Association (AUA), in collaboration with the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU), has released an amendment to the microhematuria ...
Key Takeaways Video-based research in pediatric urology visits revealed high participant interest, with over 70% consent rate, highlighting the importance of communication studies. Current ...
In this video, 4 experts discuss the highlights and take-home messages from the 2024 American Urological Association Annual Meeting.
For almost my entire career, I have recognized the importance of government funding for cancer research. These trials have provided guidance and options for the treatment of patients with cancer that ...
Based on current studies and anecdotal evidence, many of today’s urologists think it’s relatively safe to administer testosterone replacement in hypogonadal men on active surveillance or in those who ...
"The management of advanced prostate cancer has evolved significantly, driven in part by the integration of diverse biomarkers that guide treatment decisions from diagnosis through progression," says ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results